CAS 1248559-53-6 Eptifibatide Monoacetate

Send Inquiry
CAS 1248559-53-6 Eptifibatide Monoacetate
Details
CAS: 1248559-53-6
Sequence: cyclo[Mpa-homoArg-Gly-Asp-Trp-Pro-Cys-NH₂] (cyclized via disulfide bridge)
We also provide specifications from crude to 99% purity, please contact us for details!

Related documents
COA/MS/HPLC Report
Peptide Dissolution and Storage Guide
Category
Pharmaceutical Peptides / Antiplatelet GP IIb/IIIa Antagonist
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 1248559-53-6 eptifibatide monoacetate in China, also supports custom service. Welcome to wholesale bulk high quality cas 1248559-53-6 eptifibatide monoacetate from our factory. Contact us for more details.

 

Product name CAS:1248559-53-6:Eptifibatide monoacetate
Description Eptifibatide is a cyclic heptapeptide derived from snake venom disintegrin. It competitively blocks GP IIb/IIIa receptors on activated platelet surfaces, inhibits platelet aggregation and thrombus formation, and is applied in acute coronary syndrome, percutaneous coronary intervention and thrombosis mechanism research.
Peptide purity (HPLC, %) 95%/98%/99%
Molecular formula C₃₇H₅₃N₁₁O₁₁S₂ (monoacetate)
Molecular weight (Da) 892.01
Salt form Monoacetate

 

Products Description

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Full Amino Acid Sequence Molecular Formula Exact Mass (Da) Average MW (Da) N-terminal Modification C-terminal Modification Sequence Length (aa)
Eptifibatide monoacetate Eptifibatide acetate; Integrilin; CAS 1248559-53-6 GP IIb/IIIa receptor antagonist,Antiplatelet aggregation,Thrombosis inhibition,Acute coronary syndrome study,Disintegrin derived peptide,Cyclic heptapeptide Mercaptopropionyl-homoarginine-glycine-aspartic acid-tryptophan-proline-cysteinamide (disulfide cyclized, contains RGD-like recognition sequence) C₃₇H₅₃N₁₁O₁₁S₂ (monoacetate) 891.34 892.01 N-terminal mercaptopropionylation, no free amine C-terminal amidation 6 (core amino acids + Mpa terminus)

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Conditions Short-term Storage Conditions Liquid Stability Solid Powder Stability
PEP-EPT001 white powder Store at -20℃, strictly protected from light, sealed and dry, aliquoted. **Strictly prohibited from strong reducing agents** Solid powder stable for 2 years at 2-8℃ sealed and dry; prepare aqueous solutions freshly before use Stable for 72 h at 4℃; stable for 1 month at -20℃ in aliquots. **Good water solubility, freely soluble in water and physiological buffer**. Disulfide bridge is sensitive to strong reducing agents and prone to cleavage with activity loss. Tryptophan is prone to photooxidation Stable for 3 years at -20℃ under dry & dark conditions

 

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-EPT001 Cyclic heptapeptide GP IIb/IIIa antagonist that competitively blocks the final platelet aggregation pathway with potent antithrombotic effect Eptifibatide is a synthetic cyclic heptapeptide derived from rattlesnake venom disintegrin. The rigid cyclized structure maintains the active conformation of the RGD-like sequence, which binds with high affinity to glycoprotein IIb/IIIa (GP IIb/IIIa) receptors on activated platelet surfaces, competitively blocks fibrinogen binding to the receptor, thereby inhibits the common final pathway of platelet aggregation and exerts potent antithrombotic effect. Its action is reversible, platelet function recovers rapidly after discontinuation with low bleeding risk. This molecule serves as a classic tool peptide for thrombosis and hemostasis mechanism research, antiplatelet drug screening, acute coronary syndrome and peri-PCI pharmacological research, and is the active ingredient of widely used clinical intravenous antiplatelet drugs. Thrombosis and hemostasis research,Antiplatelet drug development,Acute coronary syndrome study,Peri-PCI study,Platelet activation pathway study,Cardiovascular pharmacology research Glycoprotein IIb/IIIa Receptor (GP IIb/IIIa); Final platelet aggregation pathway; Fibrinogen-receptor binding blockade

Hot Tags: cas 1248559-53-6 eptifibatide monoacetate, China cas 1248559-53-6 eptifibatide monoacetate manufacturers, suppliers, factory, 121062-08-6, 129954-34-3, 1566590-77-9, CAS 137525 51 0, CAS 1415456 99 3, CAS 910463 68 2

Send Inquiry